US 9718872
Human antibodies to middle east respiratory syndrome—coronavirus spike protein
granted A61KA61K2039/505A61K2039/507
Quick answer
US patent 9718872 (Human antibodies to middle east respiratory syndrome—coronavirus spike protein) held by REGENERON PHARMACEUTICALS, INC. expires Mon Jul 27 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Aug 01 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 27 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 25
- CPC classes
- A61K, A61K2039/505, A61K2039/507, A61K38/00, A61K39/12